Merck Stock News

Stephens Inc. AR grew its holdings in Merck & Co., Inc. (NYSE:MRK) by 3.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 456,749 shares of the companys stock after buying an additional 14,542 shares during the period. Stephens Inc. ARs holdings in Merck & []

Dearborn Partners LLC lifted its position in shares of Merck & Co., Inc. (NYSE:MRK) by 61.0% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 494,629 shares of the company’s stock after acquiring an additional 187,443 shares during the quarter. Dearborn Partners LLC’s holdings in Merck & Co., Inc. were worth $37,152,000 as of its […]

Pills from Merck and Pfizer, which limit the severity of coronavirus illnesses, are moving through the regulatory process.

Telemus Capital LLC lifted its holdings in shares of Merck & Co., Inc. (NYSE:MRK) by 14.8% in the third quarter, Holdings Channel.com reports. The institutional investor owned 19,626 shares of the company’s stock after acquiring an additional 2,536 shares during the period. Telemus Capital LLC’s holdings in Merck & Co., Inc. were worth $1,474,000 at […]

Image Provided By Unsplash The following post was written and/or published as a collaboration between Benzingas in-house sponsored content team and a financial partner of Benzinga. Pressure BioSciences, Inc. (OTCQB: PBIO ) is the biotech pioneer behind a range of pressure-based technology platforms that have been helping researchers and manufacturers across pharmaceuticals, nutraceuticals, cosmetics, agrochem, and many other industries develop more effective, reliable, and stable products for consumers. Hundreds of research and manufacturing labs worldwide are already using the technology, which relies on precision-controlled pressure to manipulate substances ranging from oils to proteins and other biomolecules. While many high value medical sciences companies like Pfizer (NYSE: PFE ), Merck (NYSE: MRK ), and AstraZeneca (NASDAQ: AZN ) are always searching for cutting-edge mechanisms like this, Pressure BioSciences, Inc. (PBI) jumped the innovation gap and has made a significant contribution to the sector.

DUBLIN, Dec. 14, 2021 /PRNewswire/ -- The "Pharmaceutical Analytical Testing Outsourcing Market Research Report by Product Type, Service, End-users, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com''s

For improved efficiency and automation of its global shipping operations, and better temperature data visibility and documentation, Merck selects Onset''s Bluetooth/IoT InTemp cold chain monitoring

Mizuho reaffirmed their buy rating on shares of Merck & Co., Inc. (NYSE:MRK) in a research report report published on Monday morning, AnalystRatings.com reports. A number of other research firms have also issued reports on MRK. Truist increased their price target on shares of Merck & Co., Inc. from $92.00 to $95.00 and gave the [] The post Merck & Co., Inc.s (MRK) Buy Rating Reaffirmed at Mizuho appeared first on ETF Daily News .

UBS Group lowered shares of Merck & Co., Inc. (NYSE:MRK) from a buy rating to a neutral rating in a research note released on Monday morning, Price Targets.com reports. They currently have $76.00 target price on the stock, down from their previous target price of $98.00. Several other research firms have also weighed in on [] The post Merck & Co., Inc. (NYSE:MRK) Downgraded by UBS Group to Neutral appeared first on ETF Daily News .

DUBLIN--(BUSINESS WIRE)--The "Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. The global multiple sclerosis drugs market is expected to grow from $21.27 billion in 2020 to $22.04 billion in 2021 at a compound annual growth rate (CAGR) of 3.6%. The market is expected to reach $25.95 billion in 2025 at a CAGR of 4%. Major players in the multiple sclerosis drugs market are Biogen, Novartis, Roche, B

The latest release from WMR titled Animal Vaccines Market Research Report 2021-2027 (by Product Type, End-User / Application, and Regions / Countries) provides an in-depth assessment of the Animal Vaccines including key market trends, upcoming technologies, industry drivers, challenges, regulatory

Merck & Co Inc (NYSE: MRK ) has announced its inaugural issuance of a $1 billion sustainability bond, which was part of an $8 billion underwritten public offering of notes that Full story available on Benzinga.com

A Pain is a distressing physical and expressive sensation, which is produced by tissue injury or illness. Moreover, diverse disorders may cause sufferings, such as multiple sclerosis, osteoarthritis, stomach ulcer, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer. The Global LATAM Pain